You just read:

Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting

News provided by

Savient Pharmaceuticals, Inc.

Nov 05, 2011, 02:00 ET